Live Breaking News & Updates on News Ratings For Reneo Pharmaceuticals Daily

Stay updated with breaking news from News ratings for reneo pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Head to Head Review: Enanta Pharmaceuticals (NASDAQ:ENTA) versus Reneo Pharmaceuticals (NASDAQ:RPHM)

Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) and Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Earnings and Valuation This table compares Reneo Pharmaceuticals and […] ....

United States , Enanta Pharmaceuticals Inc , Enanta Pharmaceuticals , Abbott Laboratories , Reneo Pharmaceuticals , News Ratings For Reneo Pharmaceuticals Daily , Reneo Pharmaceuticals Inc , Free Report , Enanta Pharmaceutical , Given Reneo Pharmaceutical , Reneo Pharmaceuticals Daily ,

Reneo Pharmaceuticals (NASDAQ:RPHM) Shares Up 1%

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) shot up 1% during mid-day trading on Friday . The company traded as high as $9.30 and last traded at $8.93. 87,418 shares were traded during mid-day trading, an increase of 3% from the average session volume of 84,853 shares. The stock had previously closed at […] ....

United States , Niall Odonnell , America Corp , Dimensional Fund Advisors , Reneo Pharmaceuticals Inc , Renaissance Technologies , Reneo Pharmaceuticals Price Performance , Reneo Pharmaceuticals , Institutional Investors Weigh In On Reneo Pharmaceuticals , Prelude Capital Management , News Ratings For Reneo Pharmaceuticals Daily , Get Rating , Director Niallo Donnell , Street Group , Fund Advisors , Reneo Pharmaceuticals Daily ,

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Director Purchases $1,000,000.00 in Stock

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) Director Niall O’donnell purchased 125,000 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The shares were bought at an average cost of $8.00 per share, for a total transaction of $1,000,000.00. Following the completion of the acquisition, the director now directly owns […] ....

Niall Odonnell , Reneo Pharmaceuticals Stock Performance , Reneo Pharmaceuticals Inc , News Ratings For Reneo Pharmaceuticals Daily , Institutional Investors Weigh In On Reneo Pharmaceuticals , Millennium Management , Renaissance Technologies , Northern Trust Corp , Reneo Pharmaceuticals , Get Rating , Director Niallo Donnell , Point Capital Management , Trust Corp , Reneo Pharmaceuticals Daily , Nasdaq Rphm , Insider Trading , Nsider Trades ,

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Short Interest Up 21.3% in March

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 115,600 shares, an increase of 21.3% from the February 28th total of 95,300 shares. Based on an average daily trading volume, of 54,900 shares, the short-interest ratio […] ....

United States , America Corp , Northern Trust Corp , Renaissance Technologies , Millennium Management , Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals Trading , Reneo Pharmaceuticals , News Ratings For Reneo Pharmaceuticals Daily , Get Rating , Trust Corp , Reneo Pharmaceuticals Daily , Nasdaq Rphm ,